Anti-Citrullinated Peptide Antibodies in Tophaceous Gout: Prevalence in a Polynesian Population.
Department of Rheumatology Greenlane Clinical Centre Auckland District Health Board Auckland, New Zealand Bone and Joint Research Group Department of Medicine Faculty of Medical and Health Sciences University of Auckland Auckland, New Zealand Department of Rheumatology Greenlane Clinical Centre Auckland District Health Board Auckland, New Zealand Bone and Joint Research Group Department of Medicine Faculty of Medical and Health Sciences University of Auckland Auckland, New Zealand Department of Anatomy with Radiology Faculty of Medical and Health Sciences University of Auckland Auckland, New Zealand Department of Rheumatology Greenlane Clinical Centre Auckland District Health Board Auckland, New Zealand Department of Molecular Medicine and Pathology Faculty of Medical and Health Sciences University of Auckland Auckland, New Zealand f.mcqueen@auckland.ac.nz.
Estine
E
Chow
Opetaia
O
Aati
Nicola
N
Dalbeth
Anthony
A
Doyle
Fiona M
FM
McQueen
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000097:blood; D001172:Arthritis, Rheumatoid / Q000175:diagnosis*; D003937:Diagnosis, Differential; D005260:Female; D006073:Gout / Q000175:diagnosis / Q000208:ethnology / Q000276:immunology; D006801:Humans; D007159:Immunologic Tests / Q000379:methods / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D009520:New Zealand / Q000453:epidemiology; D062072:Patient Acuity; D010456:Peptides, Cyclic / Q000276:immunology*; D015995:Prevalence
D000906:Antibodies; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide